Literature DB >> 15081186

Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study.

Eleftheria P Tsagalou1, Maria I Anastasiou-Nana, Christos E Charitos, Costantinos X Siafakas, Stavros G Drakos, Argirios Ntalianis, John V Terrovitis, Emmanuel M Mavrikakis, Antonios Doufas, John N Nanas.   

Abstract

UNLABELLED: Experimental studies have described an increase in ventricular fibrillation threshold (VFT) by intravenous amiodarone. The aim of this study was to examine the early time course of changes in VFT and defibrillation thresholds (DFT) after an intravenous bolus of amiodarone in an experimental pig model of transient myocardial ischemia. METHODS AND
RESULTS: VFT and relative effective ventricular refractory period (ERP) were measured in 15 anaesthetized open-chest pigs after 3 min of regional coronary ischaemia before (time 0) and 2, 15, 30, 60, and 90 min after the intravenous injection of normal saline (group A, n = 5) or amiodarone, 5 mg/kg over 15 s (group B, n = 10). DFT was measured by increasing the strength of DC shocks until defibrillation was accomplished. Amiodarone caused an increase in VFT, starting at 2 min after the infusion (11.4 +/- 8.4 mA versus 9.2 +/- 4.6 mA, P = 0.03), became significant at 15 min (13.7 +/- 6.5 mA, P = 0.009), continued to rise at 30 min (34.2 +/- 28.7 mA, P = 0.03) and reached a plateau at 60 min (50.3 +/- 37.8 mA, P = 0.008). An increase was also observed in the ERP (204 +/- 25 ms at 2 min versus 197 +/- 26 ms at baseline, P = 0.074, 211 +/- 38 ms at 15 min, P = 0.084, 212 +/- 40 ms at 30 min, P = 0.037, 220 +/- 34 ms at 60 min, P = 0.002, and 227 +/- 32 ms at 90 min, P = 0.008). No change was observed in DFT after amiodarone administration. No significant change in VFT, ERP, or DFT occurred in the control group.
CONCLUSION: In this porcine model, the intravenous administration of amiodarone increased VFT and ERP over 60 min after the injection, without effect on DFT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081186     DOI: 10.1016/j.resuscitation.2003.12.003

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

Review 1.  Effect of drugs on defibrillation capacity.

Authors:  Anna Legreid Dopp; John M Miller; James E Tisdale
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation.

Authors:  Nobuya Harayama; Shun-ichi Nihei; Keiji Nagata; Yasuki Isa; Kei Goto; Keiji Aibara; Masayuki Kamochi; Takeyoshi Sata
Journal:  J Anesth       Date:  2014-01-05       Impact factor: 2.078

3.  Dantrolene versus amiodarone for cardiopulmonary resuscitation: a randomized, double-blinded experimental study.

Authors:  Thomas Wiesmann; Dennik Freitag; Wolfgang Dersch; Daphne Eschbach; Marc Irqsusi; Thorsten Steinfeldt; Hinnerk Wulf; Carsten Feldmann
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

Review 4.  Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation.

Authors:  Takashi Tagami; Hideo Yasunaga; Hiroyuki Yokota
Journal:  Crit Care       Date:  2017-03-21       Impact factor: 9.097

5.  Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model.

Authors:  Stefan M Sattler; Anniek F Lubberding; Lasse Skibsbye; Reza Jabbari; Reza Wakili; Thomas Jespersen; Jacob Tfelt-Hansen
Journal:  J Cardiovasc Transl Res       Date:  2019-01-07       Impact factor: 4.132

6.  Development of a closed-artery catheter-based myocardial infarction in pigs using sponge and lidocaine hydrochloride infusion to prevent irreversible ventricular fibrillation.

Authors:  Rafael Dariolli; Celso K Takimura; Carlos A Campos; Pedro A Lemos; José E Krieger
Journal:  Physiol Rep       Date:  2014-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.